# Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)

> **NCT01822106** · PHASE4 · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01822106
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822106, "Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01822106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*